Cite

HARVARD Citation

    Paul, S. et al. (2019). A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia. British journal of haematology. pp. 606-608. [Online]. 
  
Back to record